Today on Pharmaceutical Processing
COVID-19 vaccine hesitancy reducing, but challenges remain
Becton Dickinson acquires smart medication device maker GSL Solutions
Regulatory See More >
Injectable anti-HIV therapies could see strong growth
The market for injectable anti-HIV therapeutics will be worth $28 billion by 2029, according to projections from the analyst and consulting firm GlobalData. GlobalData valued the broader HIV therapeutics market at $22.9 billion in 2019 across the U.S., France, Germany, Italy, Spain, U.K. and Japan. While the overall market is growing at a low single-digit…
Facility See More >
Videojet debuts continuous inkjet printer that supports pharma applications
Coding, marking and printing specialist Videojet Technologies has introduced its Videojet 1880 continuous inkjet printer. The printer includes digital features to detect potential problems that can result in manufacturing downtime. The MAXIMiZE diagnostics platform analyzes printer health and performance patterns to signal if a fault is likely to occur. In the event of a possible…
Supply Chain See More >
Moscow ramping up COVID-19 vaccination
More than half a million people in Moscow have received the first dose of COVID-19 vaccine or about 4% of its population. Now, Russia is aiming to both ramp up domestic vaccinations and exports of its Sputnik V vaccine. Moscow has been one of the few cities that has had a surplus of COVID-19…
Recalls See More >
GSK, Pfizer and J&J among the most-fined drug companies, according to study
GlaxoSmithKline (LON:GSK) paid nearly $10 billion in inflation-adjusted financial penalties between January 2003 and December 2016, the highest tally for any drug company, according to research published in JAMA. That sum was more than any other in a sampling of 26 companies paying fines inside the U.S. Pfizer (NYSE: PFE) was next in line with…
Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems
Flu vaccination worries rise in South Korea following deaths
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
